I now have comprehensive information from the textbooks. Let me craft a high-quality scenario-based question.
Scenario-Based Question: Bernard-Soulier Syndrome
Clinical Scenario
A 9-year-old girl is brought to the pediatric hematology clinic by her parents who report that she has had recurrent nosebleeds since infancy, easy bruising after minor bumps, and prolonged bleeding after a tooth extraction last year. Her parents are first cousins. There is no family history of hemophilia. Physical examination shows petechiae on her lower limbs. No hepatosplenomegaly is noted.
Laboratory investigations:
| Test | Patient Result | Reference Range |
|---|
| Platelet count | 65,000/µL | 1,50,000-4,00,000/µL |
| Peripheral smear | Giant platelets, reduced in number | Normal |
| Bleeding time | Prolonged | 2-7 min |
| PT | Normal | Normal |
| aPTT | Normal | Normal |
| Platelet aggregation with ADP | Normal aggregation | Normal |
| Platelet aggregation with collagen | Normal aggregation | Normal |
| Platelet aggregation with ristocetin | Absent/markedly reduced | Normal |
| Platelet aggregation with ristocetin + normal plasma | No correction | Corrects in vWD |
| vWF antigen level | Normal | Normal |
Questions
Q1. What is the most likely diagnosis?
A. Von Willebrand disease type 1
B. Glanzmann thrombasthenia
C. Bernard-Soulier syndrome
D. Immune thrombocytopenic purpura
Answer: C - Bernard-Soulier syndrome
Explanation: BSS is an autosomal recessive disorder caused by deficiency or dysfunction of the GPIb-IX-V complex on the platelet surface. GPIb is the receptor for von Willebrand factor (vWF), so platelets cannot adhere to damaged subendothelium. The classic triad is:
- Thrombocytopenia with giant platelets on peripheral smear
- Absent aggregation with ristocetin only (ADP, collagen, epinephrine are normal)
- Failure to correct with addition of normal plasma (distinguishes it from vWD, where normal plasma corrects the ristocetin response because it supplies functional vWF)
(Goldman-Cecil Medicine, Platelet Receptor Defects; Quick Compendium of Clinical Pathology 5th ed., §5.2.12.1)
Q2. What is the inheritance pattern, and what clue in this case supports it?
A. X-linked recessive - affects males predominantly
B. Autosomal dominant - one parent must be affected
C. Autosomal recessive - consanguinity in parents
D. Mitochondrial - maternal transmission
Answer: C - Autosomal recessive; consanguineous parents (first cousins)
Explanation: BSS is autosomal recessive, caused by mutations in GPIBA, GPIBB, or GP9 genes. Consanguinity (parents being first cousins) significantly increases the likelihood of inheriting two defective copies of the same recessive gene. The heterozygous carrier state may manifest only as mild macrothrombocytopenia (Mediterranean macrothrombocytopenia), seen in southern Europe. (Quick Compendium of Clinical Pathology 5th ed., §5.2.12.1; Goldman-Cecil Medicine)
Q3. The key test that distinguishes Bernard-Soulier syndrome from von Willebrand disease is:
A. Bleeding time
B. Platelet count
C. Ristocetin aggregation corrected by normal plasma
D. Platelet morphology on peripheral smear
Answer: C - Ristocetin aggregation corrected by normal plasma
Explanation: Both BSS and vWD show absent/reduced ristocetin-induced platelet aggregation. The critical distinguishing test is the mixing study:
- In vWD: adding normal plasma (which contains functional vWF) corrects ristocetin aggregation, because the problem is in the plasma (absent/dysfunctional vWF).
- In BSS: adding normal plasma does NOT correct ristocetin aggregation, because the defect is in the platelet receptor (GPIb-IX-V) itself - there is no GPIb to bind even normal vWF.
(Quick Compendium of Clinical Pathology 5th ed., §5.2.12.1)
Q4. How does the aggregation pattern of BSS differ from Glanzmann thrombasthenia?
| Feature | Bernard-Soulier Syndrome | Glanzmann Thrombasthenia |
|---|
| Deficient receptor | GPIb-IX-V | GPIIb-IIIa |
| Platelet size | Giant (macro) | Normal to small |
| Platelet count | Low (thrombocytopenic) | Normal |
| Ristocetin | Absent | Normal |
| ADP, collagen, epinephrine | Normal | Absent |
| Clot retraction | Normal | Abnormal |
Explanation: In BSS, ristocetin alone fails because GPIb (the vWF receptor for adhesion) is absent. In Glanzmann thrombasthenia, GPIIb-IIIa (the fibrinogen receptor for aggregation) is absent, so all agonists except ristocetin fail. (Goldman-Cecil Medicine; Quick Compendium of Clinical Pathology 5th ed.)
Q5. The patient develops heavy menstrual bleeding at age 13 and requires intervention. What is the most appropriate management?
A. Fresh frozen plasma infusion
B. Platelet transfusion and/or recombinant activated factor VII (rFVIIa)
C. Intravenous immunoglobulin (IVIG)
D. Desmopressin (DDAVP)
Answer: B - Platelet transfusion and/or rFVIIa
Explanation: Since BSS is a platelet membrane receptor defect, DDAVP (which works by releasing vWF from endothelium) and FFP are ineffective. The mainstay of treatment during bleeding episodes is:
- Platelet transfusion - provides functional GPIb-expressing platelets (risk: patients may develop alloantibodies against GPIb with repeated transfusions, making future transfusions ineffective)
- Recombinant FVIIa (rFVIIa) - used when platelet transfusions are contraindicated or alloantibodies are present
- Antifibrinolytics (tranexamic acid) can help for mucosal bleeding
(Goldman-Cecil Medicine, Platelet Receptor Defects; Quick Compendium of Clinical Pathology §5.2.12.1)
Q6. Flow cytometry of the patient's platelets would most likely show:
A. Absent CD41/CD61 (GPIIb-IIIa)
B. Absent CD42b (GPIbα)
C. Absent CD62P (P-selectin)
D. Elevated CD36 expression
Answer: B - Absent CD42b (GPIbα)
Explanation: CD42b is the flow cytometry marker for GPIbα, the main component of the GPIb-IX-V complex. Its absence (or severely reduced expression) on flow cytometry confirms BSS. This is also the standard confirmatory test when genetic testing is not immediately available. CD41/CD61 (GPIIb-IIIa) would be absent in Glanzmann thrombasthenia, not BSS. (Goldman-Cecil Medicine - "Flow cytometry usually confirms the absence of the receptor on the platelet surface")
Summary Table: BSS at a Glance
| Feature | Detail |
|---|
| Defect | GPIb-IX-V complex (GPIbα is vWF receptor) |
| Genes | GPIBA, GPIBB, GP9 |
| Inheritance | Autosomal recessive |
| Platelet count | Low (thrombocytopenia) |
| Platelet size | Giant (macro) on smear |
| Bleeding time | Prolonged |
| Ristocetin aggregation | Absent - NOT corrected by normal plasma |
| ADP/collagen/epinephrine | Normal |
| Clot retraction | Normal |
| Confirmatory test | Flow cytometry (absent CD42b) or genetic testing |
| Treatment | Platelet transfusion, rFVIIa, antifibrinolytics |